These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
555 related items for PubMed ID: 20015945
1. Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate. Mizutani M, Ito Y, Mizuno M, Nishimura H, Suzuki Y, Hattori R, Matsukawa Y, Imai M, Oliver N, Goldschmeding R, Aten J, Krediet RT, Yuzawa Y, Matsuo S. Am J Physiol Renal Physiol; 2010 Mar; 298(3):F721-33. PubMed ID: 20015945 [Abstract] [Full Text] [Related]
2. Regulation of CCN2/CTGF and related cytokines in cultured peritoneal cells under conditions simulating peritoneal dialysis. Leung JC, Chan LY, Tam KY, Tang SC, Lam MF, Cheng AS, Chu KM, Lai KN. Nephrol Dial Transplant; 2009 Feb; 24(2):458-69. PubMed ID: 18805993 [Abstract] [Full Text] [Related]
3. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis. Kariya T, Nishimura H, Mizuno M, Suzuki Y, Matsukawa Y, Sakata F, Maruyama S, Takei Y, Ito Y. Am J Physiol Renal Physiol; 2018 Feb 01; 314(2):F167-F180. PubMed ID: 28978530 [Abstract] [Full Text] [Related]
4. MicroRNA-302c modulates peritoneal dialysis-associated fibrosis by targeting connective tissue growth factor. Li X, Liu H, Sun L, Zhou X, Yuan X, Chen Y, Liu F, Liu Y, Xiao L. J Cell Mol Med; 2019 Apr 01; 23(4):2372-2383. PubMed ID: 30693641 [Abstract] [Full Text] [Related]
5. [High glucose dialysate enhances peritoneal fibrosis through upregulating glucose transporters GLUT1 and SGLT1]. Hong M, Nie Z, Chen Z, Yu X, Bao B. Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May 25; 45(6):598-606. PubMed ID: 28247603 [Abstract] [Full Text] [Related]
6. Patients with encapsulating peritoneal sclerosis have increased peritoneal expression of connective tissue growth factor (CCN2), transforming growth factor-β1, and vascular endothelial growth factor. Abrahams AC, Habib SM, Dendooven A, Riser BL, van der Veer JW, Toorop RJ, Betjes MG, Verhaar MC, Watson CJ, Nguyen TQ, Boer WH. PLoS One; 2014 May 25; 9(11):e112050. PubMed ID: 25384022 [Abstract] [Full Text] [Related]
7. Functional and structural alterations of peritoneum and secretion of fibrotic cytokines in rats caused by high glucose peritoneal dialysis solutions. Liu Y, Li JF, Liu H, Liu FY, Peng YM, Liu YH, Cheng MC, Chen GC, Zhou X. Ren Fail; 2014 Mar 25; 36(2):292-9. PubMed ID: 24152223 [Abstract] [Full Text] [Related]
8. Connective tissue growth factor and its regulation in the peritoneal cavity of peritoneal dialysis patients. Zarrinkalam KH, Stanley JM, Gray J, Oliver N, Faull RJ. Kidney Int; 2003 Jul 25; 64(1):331-8. PubMed ID: 12787426 [Abstract] [Full Text] [Related]
9. Inhibition effect of small interfering RNA of connective tissue growth factor on the expression of vascular endothelial growth factor and connective tissue growth factor in cultured human peritoneal mesothelial cells. Liu FY, Xiao L, Peng YM, Duan SB, Liu H, Liu YH, Ling GH, Yuan F, Chen JX, Fu X, Zhu JL. Chin Med J (Engl); 2007 Feb 05; 120(3):231-6. PubMed ID: 17355828 [Abstract] [Full Text] [Related]
10. TGF-β1 promotes lymphangiogenesis during peritoneal fibrosis. Kinashi H, Ito Y, Mizuno M, Suzuki Y, Terabayashi T, Nagura F, Hattori R, Matsukawa Y, Mizuno T, Noda Y, Nishimura H, Nishio R, Maruyama S, Imai E, Matsuo S, Takei Y. J Am Soc Nephrol; 2013 Oct 05; 24(10):1627-42. PubMed ID: 23990681 [Abstract] [Full Text] [Related]
11. Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis. Bellón T, Martínez V, Lucendo B, del Peso G, Castro MJ, Aroeira LS, Rodríguez-Sanz A, Ossorio M, Sánchez-Villanueva R, Selgas R, Bajo MA. Nephrol Dial Transplant; 2011 Sep 05; 26(9):2995-3005. PubMed ID: 21324976 [Abstract] [Full Text] [Related]
12. Connective tissue growth factor is correlated with peritoneal lymphangiogenesis. Kinashi H, Toda N, Sun T, Nguyen TQ, Suzuki Y, Katsuno T, Yokoi H, Aten J, Mizuno M, Maruyama S, Yanagita M, Goldschmeding R, Ito Y. Sci Rep; 2019 Aug 21; 9(1):12175. PubMed ID: 31434958 [Abstract] [Full Text] [Related]
13. Influence of glucose and inflammatory cytokines on TGF-beta1 and CTGF mRNA expressions in human peritoneal mesothelial cells. Sakamoto N, Sugimura K, Kawashima H, Tsuchida K, Takemoto Y, Naganuma T, Tatsumi S, Nakatani T. Int J Mol Med; 2005 Jun 21; 15(6):907-11. PubMed ID: 15870892 [Abstract] [Full Text] [Related]
14. Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence. Lin CY, Chen WP, Yang LY, Chen A, Huang TP. Am J Nephrol; 1998 Jun 21; 18(6):513-9. PubMed ID: 9845827 [Abstract] [Full Text] [Related]
15. Tanshinone IIA attenuates peritoneal fibrosis through inhibition of fibrogenic growth factors expression in peritoneum in a peritoneal dialysis rat model. Chunming J, Miao Z, Cheng S, Nana T, Wei Z, Dongwei C, Yuan F. Ren Fail; 2011 Jun 21; 33(3):355-62. PubMed ID: 21401363 [Abstract] [Full Text] [Related]
16. Connective tissue growth factor knockdown attenuated matrix protein production and vascular endothelial growth factor expression induced by transforming growth factor-beta1 in cultured human peritoneal mesothelial cells. Xiao L, Sun L, Liu FY, Peng YM, Duan SB. Ther Apher Dial; 2010 Feb 21; 14(1):27-34. PubMed ID: 20438517 [Abstract] [Full Text] [Related]
17. Expression and significance of SIRT6 in human peritoneal dialysis effluents and peritoneal mesothelial cells. Shi SS, Zhang YQ, Zhang LQ, Li YF, Zhou XS, Li RS. Int Urol Nephrol; 2024 Aug 21; 56(8):2659-2670. PubMed ID: 38483736 [Abstract] [Full Text] [Related]
18. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. Aroeira LS, Aguilera A, Selgas R, Ramírez-Huesca M, Pérez-Lozano ML, Cirugeda A, Bajo MA, del Peso G, Sánchez-Tomero JA, Jiménez-Heffernan JA, López-Cabrera M. Am J Kidney Dis; 2005 Nov 21; 46(5):938-48. PubMed ID: 16253736 [Abstract] [Full Text] [Related]
19. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells. Peng Y, Liu H, Liu F, Liu Y, Li J, Chen X. Nephrology (Carlton); 2006 Dec 21; 11(6):516-23. PubMed ID: 17199790 [Abstract] [Full Text] [Related]